The literature shows that GnRH antagonist protocols and GnRH agonist triggering of final oocyte maturation, especially when used in combination, may reduce OHSS and have considerable promise in preventing OHSS [19]. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.